Acute and Chronic Pheochromocytoma-Induced Cardiomyopathies: Different Prognoses?: A Systematic Analytical Review.

Medicine (Baltimore)

From the CHU Clermont-Ferrand, Endocrinology Department, Clermont-Ferrand, France (MB-L, CB, SM, BR, FD, IT); CNRS UMR 6293, Inserm GReD, Clermont-Ferrand, France (MB-L, SM, IT); CHU Clermont-Ferrand, Biostatistics unit (Clinical Research and Innovation Direction), Clermont-Ferrand, France (BP); and Clermont Université, Université d'Auvergne, Cardio Vascular Interventional Therapy and Imaging (CaVITI), Image Science for Interventional Techniques (ISIT), UMR6284, and CHU Clermont-Ferrand, Cardiology Department, Clermont-Ferrand, France (PM, RP, CV, GC, BC, J-RL, RE).

Published: December 2015

AI Article Synopsis

  • - Pheochromocytoma and paraganglioma (PPG) are rare tumors that release catecholamines and can cause severe cardiomyopathies, often diagnosed late, with patients experiencing acute symptoms like high blood pressure and chest pain.
  • - A systematic review collected 145 case reports of cardiomyopathy linked to PPG, noting similar initial symptoms between Takotsubo Cardiomyopathies (TTC) and other catecholamine-related cardiomyopathies (CC), but a higher occurrence of acute pulmonary edema in CC.
  • - TTC patients showed better recovery rates for left ventricular function both before and after surgical removal of the tumors, highlighting the importance of diagnosing PPG in cases of unexplained dilated cardi

Article Abstract

Pheochromocytoma and paraganglioma (PPG) are rare and late-diagnosed catecholamine secreting tumors, which may be associated with unrecognized and/or severe cardiomyopathies. We performed a computer-assisted systematic search of the electronic Medline databases using the MESH terms "myocarditis," "myocardial infarction," "Takotsubo," "stress cardiomyopathy," "cardiogenic shock", or "dilated cardiomyopathy," and "pheochromocytoma" or "paraganglioma" from 1961 to August 2012. All detailed case reports of cardiomyopathy due to a PPG, without coronary stenosis, and revealed by acute symptoms were included and analyzed. A total of 145 cases reports were collected (49 Takotsubo Cardiomyopathies [TTC] and 96 other Catecholamine Cardiomyopathies [CC]). At initial presentation, prevalence of high blood pressure (87.7%), chest pain (49.0%), headaches (47.6%), palpitations (46.9%), sweating (39.3%), and shock (51.0%) were comparable between CC and TTC. Acute pulmonary edema (58.3% vs 38.8%, P = 0.03) was more frequent in CC. There was no difference in proportion of patients with severe left ventricular systolic dysfunction (LV Ejection Fraction [LVEF] < 30%) at initial presentation between both groups (P = 0.15). LVEF recovery before (64.9% vs 40.8%, P = 0.005) and after surgical resection (97.7% vs 73.3%, P = 0.001) was higher in the TTC group. Death occurred in 11 cases (7.6%). In multivariate analysis, only TTC was associated with a better LV recovery (0.15 [0.03-0.67], P = 0.03). Pheochromocytoma and paraganglioma can lead to different cardiomyopathies with the same brutal and life-threatening initial clinical presentation but with a different recovery rate. Diagnosis of unexplained dilated cardiomyopathy or TTC should lead clinicians to a specific search for PPG.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058902PMC
http://dx.doi.org/10.1097/MD.0000000000002198DOI Listing

Publication Analysis

Top Keywords

acute chronic
4
chronic pheochromocytoma-induced
4
cardiomyopathies
4
pheochromocytoma-induced cardiomyopathies
4
cardiomyopathies prognoses?
4
prognoses? systematic
4
systematic analytical
4
analytical review
4
review pheochromocytoma
4
pheochromocytoma paraganglioma
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!